Thus, we hypothesize ICOS is released either by shedding or via exosomes upon cellular activation, and this may explain why lower levels of ICOS mRNA in PBMCs after activation [15], but higher levels of ICOS protein in plasma may both be associated with IPF progression. The gene discussed is ICOS; the disease is idiopathic interstitial pneumonia.